TrademarkDir
Serial #86628038
DEAD

Serial Number

86628038

Owner

Reven Pharmaceuticals, Inc.

Attorney

Michael F. Snyder

First Use Date

Dec 21, 2018

Filing Date

May 13, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #86628038 Trademark

Serial Number: 86628038 • Registration: 5686421

Serial #86628038 is a trademark filed by Reven Pharmaceuticals, Inc. on May 13, 2015. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Reven Pharmaceuticals, Inc. (3 trademarks)

600 Corporate Circle #C
Golden, CO 80401

Entity Type: 03

Trademark Details

Filing Date

May 13, 2015

Registration Date

February 26, 2019

First Use Anywhere

December 21, 2018

First Use in Commerce

December 21, 2018

Published for Opposition

October 27, 2015

Cancellation Date

September 5, 2025

Goods & Services

Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 5, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 26, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 26, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 24, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 23, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 7, 2019 SUPC
TEAS STATEMENT OF USE RECEIVED
Dec 26, 2018 EISU
USE AMENDMENT FILED
Dec 24, 2018 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 26, 2018 EXRA
SOU EXTENSION 5 GRANTED
Jun 25, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 25, 2018 AITU
SOU EXTENSION 5 FILED
Jun 22, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 22, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2017 EXRA
SOU EXTENSION 4 GRANTED
Dec 21, 2017 EX4G
SOU EXTENSION 4 FILED
Dec 21, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 21, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2017 EXRA
SOU EXTENSION 3 GRANTED
Jun 22, 2017 EX3G
SOU EXTENSION 3 FILED
Jun 22, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 22, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 24, 2016 EXRA
SOU EXTENSION 2 GRANTED
Dec 22, 2016 EX2G
SOU EXTENSION 2 FILED
Dec 22, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 22, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jun 22, 2016 EX1G
SOU EXTENSION 1 FILED
Jun 22, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 22, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 22, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 27, 2015 NPUB
PUBLISHED FOR OPPOSITION
Oct 27, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 7, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 18, 2015 PREV
ASSIGNED TO LIE
Sep 17, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 21, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 21, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 21, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2015 CNEA
ASSIGNED TO EXAMINER
Aug 19, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 21, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2015 NWOS
NEW APPLICATION ENTERED
May 16, 2015 NWAP

Related Trademarks

More from this Owner

REVEN PHARMACEUTICALS

REVEN PHARMACEUTICALS

REVEN PHARMACEUTICALS

REVEN PHARMACEUTICALS

REVEN PHARMACEUTICALS

REVEN PHARMACEUTICALS

REVEN

REVEN

REVEN

REVEN

REVEN

REVEN